NSAIDs, like piroxicam, are preferred to be the “first-line” therapeutic drugs for the treatment of RA, as they restrict the upregulation of IL-6, IL-1, TNF-α, and pro-inflammatory prostaglandins by blocking the cyclooxygenase pathway of the arachidonic acid cascade. The gene discussed is TNF; the disease is rheumatoid arthritis.